Home / Recalls / Genzyme Corporation / Genzyme Biosurgery / D-1518-2016

D-1518-2016 Class III Terminated

Recalled by Genzyme Corporation / Genzyme Biosurgery — Ridgefield, NJ

Recall Details

Product Type: Drugs
Report Date: September 28, 2016
Initiation Date: August 4, 2016
Termination Date: April 19, 2018
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 9,530 vials

Product Description

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp. Date

Distribution Pattern

nationwide

Code Information

Lot # 5RZ002; Exp. 04/18